Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems

Introduction The European Centre for Disease Prevention and Control is developing evidence-based guidance for voluntary screening, treatment and vaccine prevention of infectious diseases for newly arriving migrants to the European Union/European Economic Area. The objective of this systematic review protocol is to guide the identification, appraisal and synthesis of the best available evidence on prevention and assessment of the following priority infectious diseases: tuberculosis, HIV, hepatitis B, hepatitis C, measles, mumps, rubella, diphtheria, tetanus, pertussis, poliomyelitis (polio), Haemophilus influenza disease, strongyloidiasis and schistosomiasis. Methods and analysis The search strategy will identify evidence from existing systematic reviews and then update the effectiveness and cost-effectiveness evidence using prospective trials, economic evaluations and/or recently published systematic reviews. Interdisciplinary teams have designed logic models to help define study inclusion and exclusion criteria, guiding the search strategy and identifying relevant outcomes. We will assess the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Ethics and dissemination There are no ethical or safety issues. We anticipate disseminating the findings through open-access publications, conference abstracts and presentations. We plan to publish technical syntheses as GRADEpro evidence summaries and the systematic reviews as part of a special edition open-access publication on refugee health. We are following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols reporting guideline. This protocol is registered in PROSPERO: CRD42016045798.

[1]  G. Guyatt,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines]. , 2018, Gaceta sanitaria.

[2]  D. Ingleby,et al.  Building Responsive Health Systems to Help Communities Affected by Migration: An International Delphi Consensus , 2017, International journal of environmental research and public health.

[3]  H. Schünemann,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] , 2017, Recenti progressi in medicina.

[4]  Dominik Zenner,et al.  The impact of migration on tuberculosis epidemiology and control in high-income countries: a review , 2016, BMC Medicine.

[5]  Organización Internacional para las Migraciones.  World Migration Report 2015. Migrants and cities: new partnerships to manage mobility , 2016 .

[6]  B. Cowie,et al.  Recommendations for comprehensive post-arrival health assessment for people from refugee-like backgrounds. Australasian Society for Infectious Diseases and Refugee Health Network of Australia. , 2016 .

[7]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2015, BMJ : British Medical Journal.

[8]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[9]  A. Azcoaga-Lorenzo,et al.  HIV testing policies for migrants and ethnic minorities in EU/EFTA Member States , 2013, European journal of public health.

[10]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[11]  Gerald Gartlehner,et al.  [GRADE guidelines 15: going from evidence to recommendation - determinants of a recommendation's direction and strength]. , 2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[12]  K. Pottie,et al.  Improving delivery of primary care for vulnerable migrants: Delphi consensus to prioritize innovative practice strategies. , 2014, Canadian family physician Medecin de famille canadien.

[13]  L. Marrama,et al.  RAPID RISK ASSESSMENT Local transmission of Schistosoma haematobium in Corsica , France 16 May 2014 , 2014 .

[14]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[15]  Martin McKee,et al.  Migration and health in an increasingly diverse Europe , 2013, The Lancet.

[16]  T. Noori,et al.  HIV testing and counselling for migrant populations living in high-income countries: a systematic review , 2012, European journal of public health.

[17]  Gerald Gartlehner,et al.  [GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence]. , 2013, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[18]  C. Dye,et al.  Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries , 2012, Emerging infectious diseases.

[19]  Who Publication.  Rubella vaccines: WHO position paper--recommendations. , 2011 .

[20]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[21]  P. Tugwell,et al.  Evidence-based clinical guidelines for immigrants and refugees , 2011, Canadian Medical Association Journal.

[22]  P. Tugwell,et al.  Evaluation of evidence-based literature and formulation of recommendations for the clinical preventive guidelines for immigrants and refugees in Canada , 2011, Canadian Medical Association Journal.

[23]  Ligia Kiss,et al.  Migration and Health: A Framework for 21st Century Policy-Making , 2011, PLoS medicine.

[24]  Who Publication.  Pertussis vaccines: WHO position paper--recommendations. , 2011, Vaccine.

[25]  Who Publication.  Rubella vaccines: WHO position paper--recommendations. , 2011, Vaccine.

[26]  Who Publication.  Polio vaccines and polio immunization in the pre-eradication era: WHO position paper--recommendations. , 2010, Vaccine.

[27]  Measles vaccines: WHO position paper. , 2009, Releve epidemiologique hebdomadaire.

[28]  A. Phillips,et al.  Diagnosed and undiagnosed HIV‐infected populations in Europe , 2008, HIV medicine.

[29]  D. Zaknun,et al.  Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected women , 2008, HIV medicine.

[30]  David Moher,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.

[31]  J. Rees.  Prevalence , 2005, BMJ : British Medical Journal.

[32]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[33]  J B Brunet,et al.  [AIDS surveillance in Europe]. , 1986, Revue d'epidemiologie et de sante publique.